News Release https://www.seikagaku.co.jp/en/news.html Seikagaku Announces Resubmission of Application to Obtain Approval in the U.S. for SI-6603 https://www.seikagaku.co.jp/en/news/auto_20260310578704.html Tue, 10 Mar 2026 07:00:00 GMT 7146b98d-a4e0-4856-808c-87764faf4164 2026-03-10T07:00:00Z [Summary] Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Under Japanese GAAP) https://www.seikagaku.co.jp/en/news/auto_20260206550426.html Fri, 06 Feb 2026 07:00:00 GMT 0957bc4f-d8b4-4871-a418-74246fc8cda4 2026-02-06T07:00:00Z Seikagaku Announces Revision of Full-Year Consolidated Earnings Forecast, and Announcement of Full-Year Non-Consolidated Earnings Forecast https://www.seikagaku.co.jp/en/news/auto_20260206550341.html Fri, 06 Feb 2026 07:00:00 GMT 87356ef4-7413-4dd0-b0b4-fa8ca7037352 2026-02-06T07:00:00Z [Summary] Consolidated Financial Results (Japan GAAP) (Summary) for the First Six Months of Fiscal 2025 (Six-Month Period Ended September 30, 2025) https://www.seikagaku.co.jp/en/news/auto_20251110594303.html Mon, 10 Nov 2025 07:00:00 GMT 3bfaf9c6-7d72-4d32-9377-7d2ae56d2647 2025-11-10T07:00:00Z Seikagaku Announces an Application for Marketing Approval of SI-449, an Adhesion Barrier, as a Medical Device in Japan https://www.seikagaku.co.jp/en/news/auto_20250820544633.html Wed, 20 Aug 2025 07:00:00 GMT 860074e7-e4c6-46c2-9b2a-bfb21b5d1af9 2025-08-20T07:00:00Z Notice of Conclusion of a Definitive Agreement Regarding Co-development and Marketing Collaboration in Japan on Gel-One https://www.seikagaku.co.jp/en/news/auto_20250807533986.html Thu, 07 Aug 2025 05:00:00 GMT 5c3dba47-8a24-4e50-835d-b2d697f048ef 2025-08-07T05:00:00Z [Summary] Consolidated Financial Results (Japan GAAP) (Summary) for the First Three Months of Fiscal 2025 (Three-Month Period Ended June 30, 2025) https://www.seikagaku.co.jp/en/news/auto_20250805530543.html Tue, 05 Aug 2025 07:00:00 GMT 4701a939-0cfb-4cbb-8922-c712368a95b2 2025-08-05T07:00:00Z Notice of Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation https://www.seikagaku.co.jp/en/news/auto_20250711512189.html Fri, 11 Jul 2025 02:00:00 GMT be7012f9-bbde-425a-a465-cfbc49f485ac 2025-07-11T02:00:00Z Notice Concerning Disposal of Treasury Shares as Restricted Stock Compensation https://www.seikagaku.co.jp/en/news/auto_20250620595475.html Fri, 20 Jun 2025 08:00:00 GMT 891adabe-0e39-40fd-b576-76515664d37a 2025-06-20T08:00:00Z Convocation Notice of the 79th Ordinary General Meeting of Shareholders https://www.seikagaku.co.jp/en/news/COPY-COPY-COPY-COPY-COPY-COPY-COPY-COPY-COPY-COPY-COPY-COPY-news-906709639294258477.html Thu, 22 May 2025 01:00:00 GMT cc21d057-44cf-4315-a799-9f31cbf5f0ac 2025-05-22T01:00:00Z [Summary]Consolidated Financial Results (Japan GAAP) (Summary) for the Fiscal 2024 (Year Ended March 31, 2025) https://www.seikagaku.co.jp/en/news/auto_20250513546694.html Tue, 13 May 2025 07:00:00 GMT 8c076682-7d4c-475b-bf95-0ed54d4eee04 2025-05-13T07:00:00Z Seikagaku and Ono Reach a Basic Agreement Related to Co-development and Marketing Collaboration on Gel-One in Japan https://www.seikagaku.co.jp/en/news/auto_20250425523653.html Fri, 25 Apr 2025 06:00:00 GMT c3b2c452-5edf-41c8-b8c6-1f90beddf2f6 2025-04-25T06:00:00Z Seikagaku Announces Revision of Forecast of Full-Year Consolidated Financial Results for the Fiscal Year Ending March 31, 2025 https://www.seikagaku.co.jp/en/news/COPY-COPY-COPY-COPY-COPY-COPY-COPY-COPY-COPY-COPY-COPY-news-906709639294258477.html Wed, 26 Mar 2025 01:00:00 GMT 54e98ef5-7305-442e-81e6-2a46da19565d 2025-03-26T01:00:00Z Seikagaku Announces Receipt of a Complete Response Letter Concerning the Biologics License Application in the U.S. for SI-6603 (Generic Name: Condoliase) https://www.seikagaku.co.jp/en/news/COPY-COPY-COPY-COPY-COPY-COPY-COPY-COPY-COPY-COPY-news-906709639294258477.html Wed, 12 Mar 2025 01:00:00 GMT 6e6d07dc-1503-4c00-aa95-c7e7d19a5d82 2025-03-12T01:00:00Z Seikagaku Announces Initiation of Phase III Clinical Studies of Gel-One, a Treatment of Osteoarthritis, in Japan https://www.seikagaku.co.jp/en/news/COPY-COPY-COPY-COPY-COPY-COPY-COPY-COPY-COPY-news-906709639294258477.html Fri, 21 Feb 2025 01:00:00 GMT 00f18237-5b23-4ef4-a38e-53e9068d2dea 2025-02-21T01:00:00Z Consolidated Financial Results for the Third Quarter of Fiscal year 2024 https://www.seikagaku.co.jp/en/news/COPY-COPY-COPY-news-6239314017584867308_1.html Fri, 07 Feb 2025 02:30:00 GMT 02538f98-b36b-4303-8683-47902439f487 2025-02-07T02:30:00Z Consolidated Financial Results for the Second Quarter of Fiscal Year 2024 https://www.seikagaku.co.jp/en/news/COPY-COPY-news-6239314017584867308.html Fri, 08 Nov 2024 07:00:20 GMT 032d0a0e-e280-4e41-bbef-8a95743cc6d5 2024-11-08T07:00:20Z Seikagaku Announces Regulatory Approval in China for MucoUp, a Submucosal Injection Agent for Endoscopic Surgery, and Conclusion of a Distribution Agreement with Tozai Boeki Kaisha, Ltd. https://www.seikagaku.co.jp/en/news/COPY-COPY-COPY-COPY-COPY-COPY-COPY-COPY-news-906709639294258477.html Wed, 16 Oct 2024 08:00:00 GMT 2fb7be7a-523d-4bb1-926b-87b857dac052 2024-10-16T08:00:00Z Consolidated Financial Results for the First Quarter of Fiscal 2024 https://www.seikagaku.co.jp/en/news/COPY-COPY-news308914741901526371.html Mon, 05 Aug 2024 06:00:45 GMT 2d0fea00-6811-43a4-9e8f-02d469f52a75 2024-08-05T06:00:45Z Convocation Notice of the 78th Ordinary General Meeting of Shareholders https://www.seikagaku.co.jp/en/news/COPY-COPY-COPY-COPY-COPY-COPY-COPY-news-906709639294258477.html Thu, 23 May 2024 01:00:00 GMT ab1c937f-450d-4d46-ab28-2f2f79e04265 2024-05-23T01:00:00Z Seikagaku Announces the Biologics License Application for SI-6603 Has Been Accepted for Filing by the U.S. FDA https://www.seikagaku.co.jp/en/news/COPY-COPY-COPY-COPY-COPY-news-906709639294258477.html Tue, 14 May 2024 01:00:00 GMT f533cbb8-5b0b-4a7a-a71f-8d49df271005 2024-05-14T01:00:00Z Consolidated Financial Results for the Fiscal Year Ended March 31, 2024 https://www.seikagaku.co.jp/en/news/COPY-COPY-news-6239314017584867308_1.html Mon, 13 May 2024 02:30:00 GMT 0909c08c-bcd4-4903-b623-45c55947141e 2024-05-13T02:30:00Z Seikagaku Announces Differences between Full-Year Consolidated Financial Forecasts https://www.seikagaku.co.jp/en/news/COPY-COPY-COPY-COPY-news-906709639294258477.html Mon, 13 May 2024 01:00:00 GMT 61c43566-dcf0-4831-9448-a38825b36d62 2024-05-13T01:00:00Z Seikagaku Announces an Academic Conference Presentation on SI-6603 by Licensee Ferring Pharmaceuticals Inc. https://www.seikagaku.co.jp/en/news/COPY-COPY-COPY-COPY-COPY-COPY-news-906709639294258477.html Tue, 09 Apr 2024 01:00:00 GMT f8dcb2c4-672b-4261-8c47-c939d20f5b95 2024-04-09T01:00:00Z Consolidated Financial Results for the Third Quarter of Fiscal year 2023 https://www.seikagaku.co.jp/en/news/COPY-news-6239314017584867308_1.html Wed, 14 Feb 2024 02:30:00 GMT 40b12def-dbd2-4721-b3ec-353c29a70604 2024-02-14T02:30:00Z Consolidated Financial Results for the Second Quarter of Fiscal Year 2023 https://www.seikagaku.co.jp/en/news/COPY-news-6239314017584867308.html Wed, 08 Nov 2023 07:00:20 GMT 2a6b36a6-8e17-40b8-a809-93809332a458 2023-11-08T07:00:20Z Consolidated Financial Results for the First Quarter of Fiscal 2023 https://www.seikagaku.co.jp/en/news/COPY-news308914741901526371.html Fri, 04 Aug 2023 06:00:45 GMT 45897101-07d7-4688-bf3c-40cc90cede2d 2023-08-04T06:00:45Z Seikagaku Announces Favorable Results from a Pivotal Study for SI-449, an Adhesion Barrier https://www.seikagaku.co.jp/en/news/COPY-COPY-COPY-news-906709639294258477.html Fri, 21 Jul 2023 01:00:00 GMT 725b77c7-d4f2-4fe8-ba9c-101391f554b1 2023-07-21T01:00:00Z Seikagaku Announces the Topline Results from a Phase III Clinical Study (Additional Study) in the U.S. for SI-6603, a Treatment for Lumbar Disc Herniation https://www.seikagaku.co.jp/en/news/COPY-COPY-news-906709639294258477.html Fri, 26 May 2023 01:00:00 GMT ed052b98-0131-4062-b415-7e6ed09a40ee 2023-05-26T01:00:00Z Convocation Notice of the 77th Ordinary General Meeting of Shareholders https://www.seikagaku.co.jp/en/news/COPY-news-906709639294258477.html Mon, 22 May 2023 01:00:00 GMT 29dcb65e-a2fe-4684-bdfb-b5497e54b42e 2023-05-22T01:00:00Z Consolidated Financial Results for the Fiscal Year Ended March 31, 2023 https://www.seikagaku.co.jp/en/news/COPY-news-6616257015028908134.html Fri, 12 May 2023 07:00:20 GMT 3b0976fb-068e-4afb-bdd6-02bc13fba603 2023-05-12T07:00:20Z Consolidated Financial Results for the Thrid Quarter of Fiscal year 2022 https://www.seikagaku.co.jp/en/news/news-6239314017584867308_1.html Wed, 08 Feb 2023 06:00:00 GMT a55d3de6-99ef-4dfc-950a-dd262a1d92e4 2023-02-08T06:00:00Z Seikagaku announces Results of Acquisition of Treasury Stocks and its Completion https://www.seikagaku.co.jp/en/news/news-4799526240342982596.html Mon, 26 Dec 2022 01:00:33 GMT 7c21b879-b4a0-4ba5-94b4-25824a44b7cf 2022-12-26T01:00:33Z Seikagaku announces the Progress of Acquisition of Treasury Stocks https://www.seikagaku.co.jp/en/news/news9142429397213544319.html Thu, 01 Dec 2022 01:00:01 GMT 0d66c2b6-fa38-494f-9a87-7fd5de5e01bf 2022-12-01T01:00:01Z Seikagaku Announces a New Mid-term Management Plan (Fiscal 2022 to Fiscal 2025) https://www.seikagaku.co.jp/en/news/news-960149559171660199.html Thu, 17 Nov 2022 02:00:34 GMT cffd8fdf-aa11-48bb-8ec0-38949c5e5127 2022-11-17T02:00:34Z Seikagaku Announces Dividend from Retained Earnings (Interim Dividend) and Revision to Year-End Dividend Forecast https://www.seikagaku.co.jp/en/news/news5606918730018997837.html Tue, 08 Nov 2022 07:00:35 GMT fa6239df-a523-4ae8-8073-1a95d67468fe 2022-11-08T07:00:35Z Consolidated Financial Results for the Second Quarter of Fiscal Year 2022 https://www.seikagaku.co.jp/en/news/news-6239314017584867308.html Tue, 08 Nov 2022 07:00:20 GMT 3a95792a-e5fd-4fd3-9057-e6e8b1c3c1c5 2022-11-08T07:00:20Z Seikagaku announces the Progress of Acquisition of Treasury Stocks https://www.seikagaku.co.jp/en/news/news7884896449706177065.html Tue, 01 Nov 2022 01:00:12 GMT 39dce0db-2f19-4128-9ce0-adaf795785fb 2022-11-01T01:00:12Z Seikagaku announces the Progress of Acquisition of Treasury Stocks https://www.seikagaku.co.jp/en/news/news-1403395768302558846.html Mon, 03 Oct 2022 01:00:40 GMT 5826a171-1a1a-4e99-a802-eab146db250d 2022-10-03T01:00:40Z Seikagaku announces the Progress of Acquisition of Treasury Stocks https://www.seikagaku.co.jp/en/news/news4671078765238032208.html Thu, 01 Sep 2022 01:00:34 GMT 8013b1c3-68bb-4e6d-a952-ee87fd9c17e1 2022-09-01T01:00:34Z Consolidated Financial Results for the First Quarter of Fiscal 2022 https://www.seikagaku.co.jp/en/news/news308914741901526371.html Fri, 05 Aug 2022 06:00:45 GMT a959e501-a1f6-4c99-8321-8ded90fa0f77 2022-08-05T06:00:45Z Seikagaku announces the Progress of Acquisition of Treasury Stocks https://www.seikagaku.co.jp/en/news/news-5402890347633874633.html Mon, 01 Aug 2022 01:00:55 GMT 1b03d12a-72e9-4303-aa55-49e25bc3be81 2022-08-01T01:00:55Z Seikagaku announces the Progress of Acquisition of Treasury Stocks https://www.seikagaku.co.jp/en/news/news2852481284723328987.html Fri, 01 Jul 2022 01:00:47 GMT 437c65a4-a10b-40dd-a4c6-d194c2322656 2022-07-01T01:00:47Z Seikagaku announces the Progress of Acquisition of Treasury Stocks https://www.seikagaku.co.jp/en/news/news-172086833134733752.html Wed, 01 Jun 2022 01:00:19 GMT e46f5621-776e-4051-a254-94f33b9cb1c8 2022-06-01T01:00:19Z Convocation Notice of the 76th Ordinary General Meeting of Shareholders https://www.seikagaku.co.jp/en/news/news-906709639294258477.html Mon, 23 May 2022 01:00:00 GMT e7ab00ef-d6fc-4baf-9f25-3bc848712cf1 2022-05-23T01:00:00Z Seikagaku announces Acquisition of Treasury Stocks https://www.seikagaku.co.jp/en/news/news5055835595840562888.html Fri, 13 May 2022 07:00:22 GMT d2ca1c1f-4022-484f-b39e-19100f403646 2022-05-13T07:00:22Z Consolidated Financial Results for the Fiscal Year Ended March 31, 2022 https://www.seikagaku.co.jp/en/news/news-6616257015028908134.html Fri, 13 May 2022 07:00:20 GMT f4b27049-83ea-4751-8f06-3a5de3410e14 2022-05-13T07:00:20Z Seikagaku Initiates a Phase III Clinical Study for SI-614, a Therapeutic Agent for Dry Eye, in the U.S. https://www.seikagaku.co.jp/en/news/news-511580783500892375.html Fri, 13 May 2022 07:00:07 GMT 68cfc76a-b8e1-4078-afbf-d16ce1f9f686 2022-05-13T07:00:07Z Consolidated Financial Results for the Third Quarter of Fiscal year 2021 https://www.seikagaku.co.jp/en/news/news5934834528545843095.html Tue, 08 Feb 2022 06:00:51 GMT 0c57fe8a-64ff-4f00-9353-7a243aa2bc93 2022-02-08T06:00:51Z Seikagaku Announces the Establishment of a New Company in Canada https://www.seikagaku.co.jp/en/news/news-7134391512771400055.html Wed, 26 Jan 2022 02:00:29 GMT 29f5c3ec-4b16-4d4e-b83d-9fb69615dcf0 2022-01-26T02:00:29Z Seikagaku Announces PyroSmart NextGen recombinant BET reagent receives the Pharma Manufacturing 2021 Innovation Award https://www.seikagaku.co.jp/en/news/news2825341178129935256.html Tue, 16 Nov 2021 07:00:17 GMT 54c78bc1-002a-4719-b0d8-bff311b8e822 2021-11-16T07:00:17Z Seikagaku Announces Release of One Millionth Horseshoe Crab from Species Sustainability Project by Associates of Cape Cod, Inc. https://www.seikagaku.co.jp/en/news/news1426189488844220499.html Wed, 10 Nov 2021 06:00:16 GMT 06ba758a-7471-49cb-9a4d-1d3e6dc335d4 2021-11-10T06:00:16Z Seikagaku Announces Application for Selection of New Market Segment "Prime Market" on the Tokyo Stock Exchange https://www.seikagaku.co.jp/en/news/news-1650413517904112922.html Tue, 09 Nov 2021 07:00:49 GMT 0bd6094c-108e-4633-aa7a-44917d76223a 2021-11-09T07:00:49Z Consolidated Financial Results for the Second Quarter of Fiscal Year 2021 https://www.seikagaku.co.jp/en/news/news-7874488930003764679.html Tue, 09 Nov 2021 07:00:19 GMT c33c80cd-1422-48c6-b9fc-7e78f384558b 2021-11-09T07:00:19Z Seikagaku Announces the Launch of HyLink, an Intra-Articular Single-Injection Viscosupplement for the Treatment of Knee Osteoarthritis in Taiwan https://www.seikagaku.co.jp/en/news/news6643521154003751318.html Mon, 02 Aug 2021 01:00:18 GMT 5627a807-e93b-42bc-bae3-8b12f97a2d77 2021-08-02T01:00:18Z Consolidated Financial Results for the First Quarter of Fiscal 2021 https://www.seikagaku.co.jp/en/news/news-254126896915352832.html Fri, 30 Jul 2021 06:00:40 GMT ed15b04e-0618-405b-acd8-3ce83dbe9a77 2021-07-30T06:00:40Z Seikagaku announces Results of Acquisition of Treasury Stocks and its Completion https://www.seikagaku.co.jp/en/news/news-6264987242253847906.html Mon, 19 Jul 2021 01:00:25 GMT cbd8baf6-991c-4282-b640-a7a644faadab 2021-07-19T01:00:25Z Convocation Notice of the 75th Ordinary General Meeting of Shareholders https://www.seikagaku.co.jp/en/news/news-857113708534071889.html Mon, 24 May 2021 01:00:20 GMT 6ccd3a2a-b25a-47f0-9201-e3c86b348900 2021-05-24T01:00:20Z Ono and Seikagaku Announce the Launch of JOYCLU 30mg Intra-articular Injection, a Joint Function Improvement Agent, in Japan https://www.seikagaku.co.jp/en/news/news-1966907147076332813.html Wed, 19 May 2021 03:23:15 GMT 88c118b6-429d-4df5-85f4-1f0f3ec98fde 2021-05-19T03:23:15Z Seikagaku announces Acquisition of Treasury Stocks https://www.seikagaku.co.jp/en/news/news-2951470096856879356.html Thu, 13 May 2021 07:00:53 GMT af51baa2-4289-4001-9c62-e837d226301e 2021-05-13T07:00:53Z Seikagaku Announces Dividend from Retained Earnings (Commemorative Dividend) for the Fiscal Year Ended March 31, 2021 and Forecast of Dividend from Retained Earnings (Special Dividend) for the Fiscal Year Ending March 31, 2022 https://www.seikagaku.co.jp/en/news/news-1579983332558760560.html Thu, 13 May 2021 07:00:45 GMT 5ee4b036-3074-47b9-865a-2edef2df5aa1 2021-05-13T07:00:45Z Consolidated Financial Results for the Fiscal Year Ended March 31, 2021 https://www.seikagaku.co.jp/en/news/news5715179221700082712.html Thu, 13 May 2021 07:00:09 GMT d2bcb18a-c664-4b20-a75b-0357ee598d76 2021-05-13T07:00:09Z Seikagaku Announces Revision of Forecast of Full-Year Consolidated Financial Results for the Fiscal Year Ending March 31, 2021 https://www.seikagaku.co.jp/en/news/news-3728417600810605061.html Tue, 27 Apr 2021 04:00:12 GMT 98b1d1dd-c185-49a6-9f4d-ecda3a9c3eb9 2021-04-27T04:00:12Z Seikagaku Announces Launch of PyroSmart NextGen Recombinant LAL Reagent by Associates of Cape Cod, Inc. https://www.seikagaku.co.jp/en/news/news-3479796330727779828.html Mon, 26 Apr 2021 01:00:05 GMT efe2481e-773a-47c4-82d8-cbf0387d96b2 2021-04-26T01:00:05Z Ono and Seikagaku Announce a Manufacturing and Marketing Approval in Japan for JOYCLU 30mg Intra-articular Injection, a Joint Function Improvement Agent, for the Indication of Osteoarthritis (Knee Joint and Hip Joint) https://www.seikagaku.co.jp/en/news/news-7121260398192507292.html Tue, 23 Mar 2021 07:00:24 GMT 325fa29a-acfc-4601-a0c4-eac00529dcae 2021-03-23T07:00:24Z Consolidated Financial Results for the Thrid Quarter of Fiscal year 2020 https://www.seikagaku.co.jp/en/news/news-3027414231302802407.html Fri, 05 Feb 2021 06:00:34 GMT 01479141-6501-45b4-a69d-373672334659 2021-02-05T06:00:34Z Seikagaku Announces Forecast of Consolidated Financial Results and Dividend Forecast https://www.seikagaku.co.jp/en/news/news-8066246721662657329.html Fri, 05 Feb 2021 06:00:28 GMT c8335016-aadf-4bf7-b917-7f93c022fdcb 2021-02-05T06:00:28Z Consolidated Financial Results for the Second Quarter of Fiscal Year 2020 https://www.seikagaku.co.jp/en/news/news-6768686435108424179.html Wed, 11 Nov 2020 06:50:50 GMT 69f2ada2-a608-46c9-84e6-03a7aaecb703 2020-11-11T06:50:50Z Eisai and Seikagaku Enter into Agreement for the Marketing Alliance of SI-613, a Treatment of Osteoarthritis, in South Korea https://www.seikagaku.co.jp/en/news/news934237806691880818.html Wed, 30 Sep 2020 03:30:11 GMT c407a519-4918-41c1-8bd7-18041d278957 2020-09-30T03:30:11Z Seikagaku Announces Forecast of Consolidated Financial Results and Dividend Forecast https://www.seikagaku.co.jp/en/news/news-977631171738930470.html Thu, 24 Sep 2020 09:00:22 GMT ed09a54a-87e7-4ae7-aa48-6c2a23240a71 2020-09-24T09:00:22Z Announcement Concerning a COVID-19 Vaccine Development Partnership with VIDO-InterVac at Dalton Chemical Laboratories, Inc. https://www.seikagaku.co.jp/en/news/news6197423028356299449.html Thu, 27 Aug 2020 02:00:50 GMT fc4941bb-85c8-4ecd-a9ca-20f10995d22d 2020-08-27T02:00:50Z Consolidated Financial Results for the First Quarter of Fiscal 2020 https://www.seikagaku.co.jp/en/news/news-805878989204213332.html Fri, 31 Jul 2020 06:00:37 GMT 1ec2e499-db14-41fb-b4d7-f40abd133c25 2020-07-31T06:00:37Z (Update of Previous Disclosure) Seikagaku Announces Completion of Acquisition (Incorporation as a Subsidiary) of Dalton Chemical Laboratories, Inc. and Change in Specified Subsidiaries https://www.seikagaku.co.jp/en/news/news-556630903414938654.html Fri, 26 Jun 2020 02:19:26 GMT a68fb123-16cc-427c-89f3-e2ffa2d846a7 2020-06-26T02:19:26Z Ono and Seikagaku Announce the Results from a Phase III Clinical Study in Japan of ONO-5704/SI-613 in Patients with Knee Osteoarthritis Presented at an Academic Conference https://www.seikagaku.co.jp/en/news/news-7171966575600317343.html Thu, 11 Jun 2020 02:00:01 GMT 7a5620a2-9891-4f4b-ab0b-9ea0b1838630 2020-06-11T02:00:01Z Convocation Notice of the 74th Ordinary General Meeting of Shareholders https://www.seikagaku.co.jp/en/news/news5256917569138276891.html Thu, 04 Jun 2020 06:09:57 GMT d9b417d7-5fac-493c-bcf6-ec5adbce4fa2 2020-06-04T06:09:57Z Seikagaku Initiates a Pivotal Study for SI-449, an Adhesion Barrier https://www.seikagaku.co.jp/en/news/news7875686446160281962.html Thu, 21 May 2020 07:27:58 GMT a21a8303-9f33-4366-80fb-65f0fb1f8dfb 2020-05-21T07:27:58Z Consolidated Financial Results for Fiscal 2019 (Year Ended March 31, 2020) https://www.seikagaku.co.jp/en/news/news-1765333643565587112.html Tue, 19 May 2020 07:20:13 GMT aa8a012e-7a23-418d-8303-beb4b3421438 2020-05-19T07:20:13Z Seikagaku Announces Difference between Consolidated Financial Forecasts and Actual Results https://www.seikagaku.co.jp/en/news/news265509421181868163.html Tue, 19 May 2020 07:10:13 GMT a07202ab-e42e-4181-a02d-e4d48c858d0f 2020-05-19T07:10:13Z Seikagaku announces the Discontinuation (revocation) of Policy Against Large-scale Purchases of the Company’s Shares (Takeover Defense Measures) https://www.seikagaku.co.jp/en/news/news1363440004222638972.html Tue, 19 May 2020 07:00:43 GMT dd08311d-1c14-4c1a-a15d-a9c024a450c5 2020-05-19T07:00:43Z Eisai and Seikagaku Enter into Agreement for the Co-development and Marketing Alliance of SI-613, a Treatment of Osteoarthritis, in China https://www.seikagaku.co.jp/en/news/news604898456127551950.html Wed, 01 Apr 2020 06:00:16 GMT d492575f-48dc-4460-80fc-df0ee48a61b8 2020-04-01T06:00:16Z Seikagaku Announces Acquisition (Incorporation as a subsidiary) of Dalton Chemical Laboratories, Inc. of Canada https://www.seikagaku.co.jp/en/news/news-2205562109645044451.html Fri, 28 Feb 2020 01:00:20 GMT ac7496a5-b3e3-43bc-b0a1-89533002c3ea 2020-02-28T01:00:20Z Consolidated Financial Results for the Thrid Quarter of Fiscal year 2019 https://www.seikagaku.co.jp/en/news/news3348056736733295126.html Tue, 04 Feb 2020 06:00:35 GMT dc4f17a7-ad8c-4450-9315-6cccf9e8e942 2020-02-04T06:00:35Z Ono and Seikagaku Submit a New Drug Application for Manufacturing and Marketing Approval for ONO-5704/SI-613 for the Treatment of Osteoarthritis in Japan https://www.seikagaku.co.jp/en/news/news1095787983550148720.html Mon, 06 Jan 2020 02:43:28 GMT 46482d96-e46b-4c78-87cc-86950b406d8f 2020-01-06T02:43:28Z Consolidated Financial Results for the Second Quarter of Fiscal Year 2019 https://www.seikagaku.co.jp/en/news/news8425171209455642824.html Fri, 08 Nov 2019 07:10:43 GMT d4e6604b-4559-4192-9338-9b5c0fc3486b 2019-11-08T07:10:43Z Seikagaku Announces a New Mid-term Management Plan (Fiscal 2019 to Fiscal 2021) https://www.seikagaku.co.jp/en/news/news1678021444073648122.html Fri, 08 Nov 2019 07:09:14 GMT 227517e1-9f0f-436e-bc4d-adda835f1984 2019-11-08T07:09:14Z Seikagaku Announces the Recognition of an Extraordinary Loss (Impairment Loss) https://www.seikagaku.co.jp/en/news/news-4513420975255292418.html Fri, 08 Nov 2019 07:08:27 GMT da8d5ca4-885b-407f-b136-8d0ce71e6de5 2019-11-08T07:08:27Z Seikagaku Initiates a Phase I/II Clinical Study for SI-722 in the U.S., an Indication for Interstitial Cystitis and Bladder Pain Syndrome https://www.seikagaku.co.jp/en/news/news-5685669025233081251.html Fri, 08 Nov 2019 07:00:41 GMT 12a03aa2-0483-47bb-8469-315a4f5ac6b4 2019-11-08T07:00:41Z Consolidated Financial Results for the First Quarter of Fiscal 2019 https://www.seikagaku.co.jp/en/news/news202422697068311294.html Wed, 31 Jul 2019 06:00:55 GMT cce0c69b-81c4-4006-9e21-f08f4e741172 2019-07-31T06:00:55Z Convocation Notice of the 73rd Ordinary General Meeting of Shareholders https://www.seikagaku.co.jp/en/news/news-6052525725494131448.html Tue, 28 May 2019 00:00:29 GMT ec0f7ac6-01c4-49c8-a5a9-99e9a1f25839 2019-05-28T00:00:29Z Consolidated Financial Results for Fiscal 2018 (Year Ended March 31, 2019) https://www.seikagaku.co.jp/en/news/news6776046943190839319.html Fri, 10 May 2019 07:00:16 GMT c16e3e66-58b3-471e-b0ed-eb230076d745 2019-05-10T07:00:16Z Seikagaku Announces Revision of Consolidated Financial Forecasts for the Fiscal 2018 ending March 2019 https://www.seikagaku.co.jp/en/news/news-8144977013339826171.html Tue, 23 Apr 2019 06:00:20 GMT 8ee81dde-df5f-4cdb-88be-b7792fb448e5 2019-04-23T06:00:20Z Seikagaku Launches HyLink, an Intra-Articular Single-Injection Viscosupplement for the Treatment of Knee Osteoarthritis in Italy https://www.seikagaku.co.jp/en/news/news-6617037418084939175.html Fri, 22 Mar 2019 06:00:59 GMT 7ff24645-931a-4042-9b04-7fd1d281d23c 2019-03-22T06:00:59Z Ono and Seikagaku Announce the Topline Results from Phase III Confirmatory Study of ONO-5704/SI-613 in Patients with Knee Osteoarthritis in Japan https://www.seikagaku.co.jp/en/news/news-7734112843911996096.html Tue, 19 Feb 2019 01:30:03 GMT 0cae7b25-66f3-49ad-a212-b569c5ea703d 2019-02-19T01:30:03Z Consolidated Financial Results for the Thrid Quarter of Fiscal year 2018 https://www.seikagaku.co.jp/en/news/news-7166172243684064313.html Tue, 05 Feb 2019 01:30:02 GMT 761b8bd0-f4c2-4424-b126-dd69305ec32d 2019-02-05T01:30:02Z Consolidated Financial Results for the Second Quarter of Fiscal Year 2018 https://www.seikagaku.co.jp/en/news/news-2859405593799969936.html Wed, 07 Nov 2018 07:00:33 GMT 5aa35dad-faf9-4a8c-bf7e-6d640e971c15 2018-11-07T07:00:33Z Seikagaku and Kaken Announce the Launch of HERNICORE 1.25 Units for Intradiscal Injection in Japan, Indicated for Treatment of Lumbar Disc Herniation https://www.seikagaku.co.jp/en/news/news-6617037418084939174.html Tue, 31 Jul 2018 06:01:59 GMT defd99fd-1ed6-438a-9089-cb0b5a6d9ad4 2018-07-31T06:01:59Z Consolidated Financial Results for the First Quarter of Fiscal 2018 https://www.seikagaku.co.jp/en/news/news-1902568364278670216.html Tue, 31 Jul 2018 06:00:01 GMT 8aa048f5-787d-4402-9f5a-a425119b0655 2018-07-31T06:00:01Z Seikagaku announces Results of Acquisition of Treasury Stocks and its Completion https://www.seikagaku.co.jp/en/news/news5791518756901828388.html Thu, 05 Jul 2018 01:00:39 GMT fa2c0a54-1374-4105-8655-b2dcc2aebf7d 2018-07-05T01:00:39Z Seikagaku announces the Progress of Acquisition of Treasury Stocks https://www.seikagaku.co.jp/en/news/news8964952954659673554.html Mon, 02 Jul 2018 01:00:58 GMT 00b98155-857c-412f-b882-1ead30d5a714 2018-07-02T01:00:58Z Seikagaku announces Acquisition of Treasury Stocks https://www.seikagaku.co.jp/en/news/news8964952954659673553.html Thu, 14 Jun 2018 08:00:58 GMT 134ff675-9610-4d42-870d-2cfa136e6d22 2018-06-14T08:00:58Z Convocation Notice of the 72nd Ordinary General Meeting of Shareholders https://www.seikagaku.co.jp/en/news/news2521887670768960754.html Tue, 29 May 2018 07:00:10 GMT cc3bdac3-3386-4814-87c3-5ccc32e40fc1 2018-05-29T07:00:10Z Seikagaku and Kaken Announce the Listing in the National Health Insurance Drug Price List and Launch Date of HERNICORE 1.25 Units for Intradiscal Injection in Japan, Indicated for Treatment of Lumbar Disc Herniation https://www.seikagaku.co.jp/en/news/news937786191417722218.html Tue, 22 May 2018 02:00:25 GMT 83ade292-35ef-47d0-92c4-9e55879230ab 2018-05-22T02:00:25Z Seikagaku Initiates a Clinical Trial for SI-449, an Adhesion Barrier https://www.seikagaku.co.jp/en/news/news205363412842495412.html Mon, 21 May 2018 01:00:44 GMT 9ae591a9-8143-4c01-bf0e-56c7091d6812 2018-05-21T01:00:44Z Consolidated Financial Results for Fiscal 2017 (Year Ended March 31, 2018) https://www.seikagaku.co.jp/en/news/news-2510187670321957962.html Fri, 11 May 2018 07:00:57 GMT b7ea97ab-cc29-40a7-bbc9-6a8a2777e57a 2018-05-11T07:00:57Z Seikagaku Announces Revision of Consolidated Financial Forecasts for the Fiscal 2017 ending March 2018 https://www.seikagaku.co.jp/en/news/news3969522438608648788.html Fri, 30 Mar 2018 06:00:55 GMT 2b8d8ccc-dd55-41ea-b4bc-265069ae0bd9 2018-03-30T06:00:55Z Seikagaku Announces New Drug Application Approval of HERNICORE 1.25 Units for Intradiscal Injection in Japan, Indicated for Treatment of Lumbar Disc Herniation. https://www.seikagaku.co.jp/en/news/news9139866591419356254.html Fri, 23 Mar 2018 06:00:29 GMT 6a2b8a75-e832-425a-94ed-135588121ca0 2018-03-23T06:00:29Z Seikagaku Initiates a Phase III Clinical Trial (Additional Study) in the U.S. for SI-6603, Indicated for Treatment of Lumbar Disc Herniation https://www.seikagaku.co.jp/en/news/news2672134045652054450.html Mon, 19 Feb 2018 01:00:09 GMT 6de0f8e8-ce34-4027-bccc-7133c43b6d1f 2018-02-19T01:00:09Z Consolidated Financial Results for the Thrid Quarter of Fiscal year 2017 https://www.seikagaku.co.jp/en/news/news-3196631177821462376.html Fri, 02 Feb 2018 06:00:34 GMT 8acc74c9-8259-49f4-a5cf-0d7c4c0efa9b 2018-02-02T06:00:34Z Consolidated Financial Results for the Second Quarter of Fiscal Year 2017 https://www.seikagaku.co.jp/en/news/news1096573869592970066.html Tue, 07 Nov 2017 07:00:36 GMT 9ed22c28-17da-437c-a89d-b05db7e7201b 2017-11-07T07:00:36Z Seikagaku Announces the Results of SI-6603 Phase III Clinical Trials in the U.S., Indicated for Treatment of Lumbar Disc Herniation https://www.seikagaku.co.jp/en/news/news-4117221591943019463.html Tue, 07 Nov 2017 06:59:37 GMT d3c9e657-9326-4c7b-ac9a-0138b722bbde 2017-11-07T06:59:37Z Ono and Seikagaku Announce Initiation of a Late-Stage Phase II Clinical Trial of SI-613 for Treatment of Enthesopathy https://www.seikagaku.co.jp/en/news/news-2761245565369345768.html Thu, 28 Sep 2017 06:00:39 GMT f2f5225d-a53a-4143-8c26-fb6695eaef8d 2017-09-28T06:00:39Z Ono and Seikagaku Reach a Definitive Agreement Related to Co-development and Marketing Collaboration on SI-613 for the Treatment of Osteoarthritis in Japan https://www.seikagaku.co.jp/en/news/news7888013857805441317.html Fri, 01 Sep 2017 00:00:48 GMT 2ec82829-1d72-46bc-9909-a8a55dd035ea 2017-09-01T00:00:48Z Consolidated Financial Results for the First Quarter of Fiscal 2017 https://www.seikagaku.co.jp/en/news/news-1902568364278670215.html Mon, 31 Jul 2017 06:00:01 GMT 8c653b3f-de89-4864-86bf-116468f92208 2017-07-31T06:00:01Z Seikagaku Initiates Phase II Study of SI-613 for Treatment of Knee Osteoarthritis in the U.S. https://www.seikagaku.co.jp/en/news/news-4263200737221477009.html Fri, 16 Jun 2017 04:00:28 GMT 27d637cf-53f2-4fd0-b1d4-a4f8ee21141a 2017-06-16T04:00:28Z Consolidated Financial Results for Fiscal 2016 (Year Ended March 31, 2017) https://www.seikagaku.co.jp/en/news/news-2510187670321957961.html Fri, 12 May 2017 07:00:57 GMT dad3a526-ec84-4dfa-9f32-e4d4d6ab08a0 2017-05-12T07:00:57Z Seikagaku and Ono Reach a Basic Agreement Related to Co-development and Marketing Collaboration on SI-613 for the Treatment of Osteoarthritis in Japan https://www.seikagaku.co.jp/en/news/news2332270676186067170.html Fri, 12 May 2017 06:59:27 GMT 00c84897-5a1e-44b6-a921-33baa5dca8d1 2017-05-12T06:59:27Z Seikagaku Announces Dividend from Retained Earnings (70th Anniversary Commemorative Dividend) https://www.seikagaku.co.jp/en/news/news2521887670768960753.html Fri, 12 May 2017 06:59:10 GMT e7d69b97-8f31-4d94-a627-805fdee35b31 2017-05-12T06:59:10Z Consolidated Financial Results for the Thrid Quarter of Fiscal 2016 https://www.seikagaku.co.jp/en/news/news-7883425562075205458.html Fri, 03 Feb 2017 06:00:04 GMT af8de936-3624-4740-8dc9-b8996254e0fe 2017-02-03T06:00:04Z Seikagaku Initiates Phase III Study of SI-613 for Treatment of Osteoarthritis in Japan https://www.seikagaku.co.jp/en/news/news2079434330961233616.html Fri, 03 Feb 2017 05:59:26 GMT 25bc4971-513f-41e4-994f-7978d63ea814 2017-02-03T05:59:26Z Consolidated Financial Results for the Second Quarter of Fiscal Year 2016 https://www.seikagaku.co.jp/en/news/news-5718293949345822449.html Tue, 08 Nov 2016 07:01:04 GMT 92dcb5f2-13f0-4172-866a-9cca3b2bb578 2016-11-08T07:01:04Z Seikagaku Announces Exclusive Distributorship Agreement in the U.S. for VISCO-3, A Three-Injection Viscosupplement Product https://www.seikagaku.co.jp/en/news/news-803880410005361723.html Tue, 08 Nov 2016 07:00:45 GMT bd939520-2fe6-434b-964f-ed799d77fdef 2016-11-08T07:00:45Z Seikagaku Announces the Conclusion of an Exclusive Worldwide License Agreement (excluding Japan) for SI-6603, a Novel Treatment for Lumbar Disc Herniation https://www.seikagaku.co.jp/en/news/news-2557126754645424970.html Mon, 29 Aug 2016 07:00:21 GMT 62e5111b-85d7-4b44-bc9d-1d6b5aa6f695 2016-08-29T07:00:21Z Seikagaku announces Results of Acquisition of Treasury Stocks and its Completion https://www.seikagaku.co.jp/en/news/news5791518756901828387.html Mon, 01 Aug 2016 01:00:39 GMT 7a4ac13e-dc11-4f22-9d8f-84965a985d0f 2016-08-01T01:00:39Z Consolidated Financial Results for the First Quarter of Fiscal 2016 https://www.seikagaku.co.jp/en/news/news8772348854738085367.html Thu, 28 Jul 2016 06:00:43 GMT 3fd9982a-bd08-4e95-bc56-49885e1fe60a 2016-07-28T06:00:43Z Seikagaku announces the conclusion of a Letter of Intent for an Overseas Exclusive License Agreement for SI-6603, a Novel Treatment for Lumbar Disc Herniation https://www.seikagaku.co.jp/en/news/news-2249073664229740892.html Wed, 15 Jun 2016 08:01:11 GMT 39de17bd-9d19-4988-9a1d-65b27c6a6806 2016-06-15T08:01:11Z Seikagaku announces Acquisition of Treasury Stocks https://www.seikagaku.co.jp/en/news/news8964952954659673551.html Wed, 15 Jun 2016 08:00:58 GMT ef54d54e-7ff4-4786-a674-be31958b1f6d 2016-06-15T08:00:58Z Consolidated Financial Results for Fiscal 2015 (Year Ended March 31, 2016) https://www.seikagaku.co.jp/en/news/news6521970784609661421.html Thu, 12 May 2016 07:00:28 GMT 06ffd036-444a-4d9e-b578-6a588413aa1b 2016-05-12T07:00:28Z Seikagaku Announces a New Mid-term Management Plan (Fiscal 2016 to Fiscal 2018) https://www.seikagaku.co.jp/en/news/news-5995174949473915641.html Thu, 12 May 2016 06:59:59 GMT fa894f16-31f7-4a39-b853-60556c3d40b2 2016-05-12T06:59:59Z Seikagaku Announces a Change in Sales Partner for MucoUp Surgical Aid for Endoscopic Mucosal Resection in Japan https://www.seikagaku.co.jp/en/news/news-7947984288045582779.html Thu, 10 Mar 2016 06:30:41 GMT c8c96e93-93c2-4fdf-9388-df7e9d3070db 2016-03-10T06:30:41Z Seikagaku Announces New Drug Application Approval for the Ophthalmic Surgical Aid SHELLGAN 0.5 Ophthalmic Viscoelastic Solution https://www.seikagaku.co.jp/en/news/news8815446617087795367.html Mon, 15 Feb 2016 06:00:33 GMT a1d6f873-acbf-45b2-be82-4670d4fee32b 2016-02-15T06:00:33Z Consolidated Financial Results for the Thrid Quarter of Fiscal 2015 https://www.seikagaku.co.jp/en/news/news5067650860891968439.html Tue, 02 Feb 2016 06:01:25 GMT 0ab5c56c-ecab-48df-b260-dcbb5fa539b9 2016-02-02T06:01:25Z Seikagaku Announces Discontinuation of Development of SI-657,an Additional Indication for ARTZ https://www.seikagaku.co.jp/en/news/news89045998117713733.html Tue, 02 Feb 2016 06:00:10 GMT 2f3d0d37-9474-4aed-87e8-30f88d702ae2 2016-02-02T06:00:10Z Seikagaku Announces U.S. FDA Approval for VISCO-3, a Joint Function Improving Agent Supplied as a Three-Injection Kit https://www.seikagaku.co.jp/en/news/news7985944770373777461.html Thu, 24 Dec 2015 15:00:47 GMT 49396056-5ddc-476b-99f0-be8168a0089c 2015-12-24T15:00:47Z Consolidated Financial Results for the Second Quarter of Fiscal Year 2015 https://www.seikagaku.co.jp/en/news/news-3185531173435684114.html Fri, 06 Nov 2015 06:00:34 GMT 4081badb-c6d6-4b25-b8ac-4222c0ddb047 2015-11-06T06:00:34Z Seikagaku Announces Termination of the License Agreement with Can-Fite BioPharma Ltd. for a Therapeutic Agent for Rheumatoid Arthritis https://www.seikagaku.co.jp/en/news/news4832097301650678544.html Fri, 28 Aug 2015 00:00:00 GMT 7f1ee757-ee5e-459a-86a8-cafbbb3f65d4 2015-08-28T00:00:00Z Consolidated Financial Results for the First Quarter of Fiscal 2015 https://www.seikagaku.co.jp/en/news/news-8878575230647804731.html Fri, 31 Jul 2015 06:00:00 GMT e63a5be4-779d-4025-9acc-eb77a5def15d 2015-07-31T06:00:00Z Consolidated Financial Results for Fiscal 2014 (Year Ended March 31, 2015) https://www.seikagaku.co.jp/en/news/news1994753581371280480.html Mon, 11 May 2015 15:00:00 GMT 22a97b03-a534-4a4a-9813-fd75c96d2800 2015-05-11T15:00:00Z Consolidated Financial Results for the Thrid Quarter of Fiscal 2014 https://www.seikagaku.co.jp/en/news/news3607525159606409413.html Tue, 03 Feb 2015 06:00:00 GMT 11a4bfb1-78fc-407a-849b-2a0c12ab5ba6 2015-02-03T06:00:00Z Seikagaku Announces the Start of Operation of ARTZ Dispo Production Facilities (No. 5 Production Building at the Takahagi Plant) https://www.seikagaku.co.jp/en/news/news-7548817595171279880.html Fri, 09 Jan 2015 06:00:00 GMT effa911e-ec47-4db0-8367-1a14f467cb5c 2015-01-09T06:00:00Z Consolidated Financial Results for the Second Quarter of Fiscal Year 2014 https://www.seikagaku.co.jp/en/news/news7174924664202881889.html Fri, 07 Nov 2014 07:00:00 GMT aa249bdc-6380-49da-b678-a7d3c8acc6fa 2014-11-07T07:00:00Z Seikagaku Announces the Opening of the SEIKAGAKU U.S.A. Representative Office https://www.seikagaku.co.jp/en/news/news5062880148746622349.html Thu, 16 Oct 2014 02:00:00 GMT e82a3319-64c3-4396-960e-44aada6f9916 2014-10-16T02:00:00Z Consolidated Financial Results for the First Quarter of Fiscal Year 2014 https://www.seikagaku.co.jp/en/news/news-3596301282190168470.html Thu, 31 Jul 2014 06:00:00 GMT 5ec2b125-98d4-4d7c-b51b-96804bf0bf74 2014-07-31T06:00:00Z Seikagaku Announces Results of Phase III Clinical Trial in Japan for SI-6603, Indicated for Treatment of Lumbar Disc Herniation https://www.seikagaku.co.jp/en/news/news8851728221011669493.html Thu, 05 Jun 2014 01:38:00 GMT 72cac9cc-83a2-47b7-9426-642ff50949e4 2014-06-05T01:38:00Z Consolidated Financial Results for Fiscal 2013 (Year Ended March 31, 2014) https://www.seikagaku.co.jp/en/news/news-771007514740059973.html Tue, 13 May 2014 07:00:00 GMT bfb3a4f2-fdd0-4c48-89c4-206382548802 2014-05-13T07:00:00Z Seikagaku Initiates a Phase II/III Clinical Trial for SI-614, Indicated for Treatment of Dry Eye, in the U.S. https://www.seikagaku.co.jp/en/news/news-7861841456822061.html Wed, 07 May 2014 02:01:00 GMT 9d5d52d1-57ae-4d63-b7f7-ce74bc9da14e 2014-05-07T02:01:00Z Consolidated Financial Results for the Thrid Quarter of Fiscal 2013 https://www.seikagaku.co.jp/en/news/news-6410467755590934453.html Mon, 03 Feb 2014 15:00:00 GMT 032b6f06-30c1-4bd7-ab59-f43cabf490dc 2014-02-03T15:00:00Z Seikagaku Submits New Drug Application for SI-6603 in Japan for Treatment of Lumbar Disc Herniation https://www.seikagaku.co.jp/en/news/news-4618029207386245799.html Wed, 29 Jan 2014 15:00:00 GMT 4fd82a7f-6e53-481a-a4a4-9ee2ed8f5f5e 2014-01-29T15:00:00Z Seikagaku Announces Confirmation of Victory in the Gel-One Patent Infringement Lawsuit https://www.seikagaku.co.jp/en/news/news1526063804369767910.html Mon, 13 Jan 2014 15:00:00 GMT 02856a2f-6281-446d-8b41-5e2d46ba7ead 2014-01-13T15:00:00Z Consolidated Financial Results for the Second Quarter of Fiscal Year 2013 https://www.seikagaku.co.jp/en/news/news7626537803915579464.html Tue, 05 Nov 2013 15:00:00 GMT fa7b2e05-1075-4285-a6f7-08c9edca2e07 2013-11-05T15:00:00Z Seikagaku Announces Top-Line Results from a Phase III Clinical Trial for SI-6603, Indicated for Treatment of Lumbar Disc Herniation, in Japan https://www.seikagaku.co.jp/en/news/news5255874059685281500.html Tue, 06 Aug 2013 15:00:00 GMT 039e5589-7958-40ac-85bc-11ffedfc53b7 2013-08-06T15:00:00Z Consolidated Financial Results for the First Quarter of Fiscal Year 2013 https://www.seikagaku.co.jp/en/news/news-1722427064721333873.html Mon, 29 Jul 2013 15:05:00 GMT 6e9bf558-6c36-468e-9c49-28f67ffd6e86 2013-07-29T15:05:00Z Revision of Dividend Forecast for Year Ending March 31, 2014 and Abolition of the Shareholder Special Benefit Plan https://www.seikagaku.co.jp/en/news/news-463151903723301971.html Mon, 29 Jul 2013 15:00:00 GMT 99d6e60a-9cf1-422a-9b3c-ddb109fd15d3 2013-07-29T15:00:00Z Consolidated Financial Results for Fiscal 2012 (Year Ended March 31, 2013) https://www.seikagaku.co.jp/en/news/news6745252427086060195.html Thu, 09 May 2013 15:00:00 GMT fd357198-843a-4d79-8f48-df46a10cb44d 2013-05-09T15:00:00Z Seikagaku Initiates a Phase III Clinical Trial for SI-6603, Indicated for Treatment of Lumbar Disc Herniation, in the U.S. https://www.seikagaku.co.jp/en/news/news-8389304594306297592.html Mon, 22 Apr 2013 15:00:00 GMT 1e79eb94-2661-4332-9cc2-d03247596a84 2013-04-22T15:00:00Z Seikagaku Initiates a Phase II Clinical Trial for SI-613, Indicated for Treatment of Knee Osteoarthritis https://www.seikagaku.co.jp/en/news/news1706982899161682276.html Wed, 06 Feb 2013 15:00:00 GMT 3b03f463-1477-448b-8de7-4ec5e4f123b5 2013-02-06T15:00:00Z Consolidated Financial Results for the Thrid Quarter of Fiscal 2012 https://www.seikagaku.co.jp/en/news/news5809219422640098225.html Fri, 01 Feb 2013 15:00:00 GMT b38944e3-8bce-44b2-bb61-0b456ab3dd43 2013-02-01T15:00:00Z Seikagaku Announces Changes in the Organization and Personnel https://www.seikagaku.co.jp/en/news/news-6746527208385334200.html Mon, 14 Jan 2013 15:00:00 GMT 468e16f8-c183-4993-8a92-12e21eeb5c8a 2013-01-14T15:00:00Z Seikagaku and Kaken Conclude an Exclusive Distributorship Agreement for SI-6603, Indicated for Treatment of Lumbar Disc Herniation, in Japan https://www.seikagaku.co.jp/en/news/news8525580266182897192.html Mon, 24 Dec 2012 15:00:00 GMT 435ca93f-8f47-4666-a088-d9c33686e4e6 2012-12-24T15:00:00Z Consolidated Financial Results for the Second Quarter of Fiscal Year 2012 https://www.seikagaku.co.jp/en/news/news-7044705483403903630.html Mon, 05 Nov 2012 15:00:00 GMT c2ae1a9a-5dfd-49a5-aeea-d34b52f9e4da 2012-11-05T15:00:00Z Seikagaku Announces the Completion of New Production Facilities for Gel-One https://www.seikagaku.co.jp/en/news/news-4555179796581617762.html Sun, 30 Sep 2012 15:00:00 GMT a0e4d9c0-6ca3-495b-8f58-b0ce60d101f8 2012-09-30T15:00:00Z Seikagaku announces the revision of financial forecast for the first six-month of fiscal 2012 ending March 2013 https://www.seikagaku.co.jp/en/news/news5020156040804545880.html Tue, 25 Sep 2012 15:00:01 GMT 2da456f4-cc58-4f16-8e2b-03bc120389c4 2012-09-25T15:00:01Z The U.S. Court Ruled on Gel-One Patent Infringement Case https://www.seikagaku.co.jp/en/news/news4713318363748381414.html Thu, 09 Aug 2012 15:00:00 GMT d7f4ebc1-bde1-4047-b504-e95153a677ce 2012-08-09T15:00:00Z Consolidated Financial Results for the First Quarter of Fiscal Year 2012 https://www.seikagaku.co.jp/en/news/news-5107444532303051093.html Mon, 30 Jul 2012 15:00:00 GMT f9a12b60-ea29-47cd-bd83-3da9bb567c9b 2012-07-30T15:00:00Z Consolidated Financial Results for Fiscal 2011 (Year Ended March 31, 2012) https://www.seikagaku.co.jp/en/news/news845442946022377332.html Wed, 09 May 2012 15:10:00 GMT 568b677d-6ab2-4258-829d-d6deab2af83b 2012-05-09T15:10:00Z Seikagaku Announces a New Mid-term Management Plan https://www.seikagaku.co.jp/en/news/news-8673546247063899569.html Wed, 09 May 2012 15:05:00 GMT 7991e3c9-ee16-4e6f-9e08-d029524be7be 2012-05-09T15:05:00Z Seikagaku and Kaken Conclude a Basic Distributorship Agreement for SI-6603, Indicated for Treatment of Lumbar Disc Herniation https://www.seikagaku.co.jp/en/news/news-7805973773225002250.html Wed, 09 May 2012 15:00:00 GMT 2babe1cd-286c-470a-bcb0-1fbe676e6a6b 2012-05-09T15:00:00Z Seikagaku and Biotie Agree to Terminate the Anti-VAP-1 Monoclonal Antibody License Agreement https://www.seikagaku.co.jp/en/news/news88919123472684852.html Mon, 23 Apr 2012 15:00:00 GMT ca29aed0-49a1-4d73-8c45-454cedc40ef6 2012-04-23T15:00:00Z Consolidated Financial Results for the Thrid Quarter of Fiscal 2011 https://www.seikagaku.co.jp/en/news/news-4059216129191801668.html Thu, 02 Feb 2012 15:00:00 GMT 826088be-73ff-4163-bb5c-2b4c03b4259c 2012-02-02T15:00:00Z Seikagaku Initiates a Phase II Clinical Trial in the United States for SI-614, Indicated for Treatment of Dry Eye https://www.seikagaku.co.jp/en/news/news-7783941759815460512.html Sun, 22 Jan 2012 15:00:00 GMT 75d4962b-82ac-41fc-a3eb-5e09e04da1d1 2012-01-22T15:00:00Z Seikagaku Announces a Change in Sales Partner for SUPARTZ in the U.S. https://www.seikagaku.co.jp/en/news/news-5468104627612281011.html Wed, 04 Jan 2012 15:00:00 GMT 13c782c3-e95f-42c7-bf85-cb0c23df0826 2012-01-04T15:00:00Z Announcement of the Absorption-type Merger (Simple merger, Short-form merger) of a Consolidated Subsidiary https://www.seikagaku.co.jp/en/news/news8676889455526153865.html Mon, 19 Dec 2011 15:00:00 GMT 1222d9a2-32de-457e-a86b-edd78c70f8ca 2011-12-19T15:00:00Z Seikagaku announces the start of a Phase III clinical trial in Japan for SI-6603, indicated for treatment of lumbar disc herniation https://www.seikagaku.co.jp/en/news/news1683232032464778708.html Wed, 09 Nov 2011 15:00:00 GMT 8333aec2-152f-4163-8b1d-8b082796205e 2011-11-09T15:00:00Z Consolidated Financial Results for the Second Quarter of Fiscal 2011 https://www.seikagaku.co.jp/en/news/news-4572701460375874304.html Mon, 07 Nov 2011 15:00:00 GMT cb114c63-54c8-43e8-bed6-f2973af3f096 2011-11-07T15:00:00Z Announcement of the Transfer of Emdogain Gel, a Medical Device Used in Dentistry https://www.seikagaku.co.jp/en/news/news1275467906997079881.html Mon, 10 Oct 2011 15:00:00 GMT 669f538c-b7ab-4b28-95e4-ce42f86bc79d 2011-10-10T15:00:00Z Seikagaku announces the revision of financial forecast for the first six-month of fiscal 2011 ending March 2012 https://www.seikagaku.co.jp/en/news/news-9031491716824959917.html Tue, 27 Sep 2011 15:00:00 GMT caa8e898-0c62-45f6-b840-3d8464a53c0f 2011-09-27T15:00:00Z Seikagaku announces an additional clinical trial in Japan for SI-6603, indicated for treatment of lumbar disc herniation https://www.seikagaku.co.jp/en/news/news5109380886868944488.html Tue, 09 Aug 2011 15:00:00 GMT d28b61c9-5eb1-458b-9256-3873a68127d8 2011-08-09T15:00:00Z Consolidated Financial Results for the First Quarter of Fiscal Year 2011 https://www.seikagaku.co.jp/en/news/news649233527859245110.html Thu, 28 Jul 2011 15:00:00 GMT e961d159-d9f4-4ab8-a66a-9ee958e0fe08 2011-07-28T15:00:00Z Consolidated Financial Results for Fiscal 2010 (Year Ended March 31, 2011) https://www.seikagaku.co.jp/en/news/news8933238890355859728.html Tue, 10 May 2011 15:15:00 GMT ab527e33-479a-4f92-90bc-ee6b50ead8a7 2011-05-10T15:15:00Z Notice of Expansion of ARTZ Dispo® Production Facilities (Construction of the No. 5 Production Building at the Takahagi Plant) https://www.seikagaku.co.jp/en/news/news3570290092855955021.html Tue, 10 May 2011 15:10:00 GMT 4fc2ab9e-5973-4f48-99db-08d2f985dc6e 2011-05-10T15:10:00Z Notice Regarding the Impact of the Great East Japan Earthquake(Third Report) https://www.seikagaku.co.jp/en/news/news8237095577588594157.html Tue, 10 May 2011 15:05:00 GMT cca17556-83bb-4fdf-ad93-0284a240e64f 2011-05-10T15:05:00Z Notice Regarding Lawsuits to Seikagaku https://www.seikagaku.co.jp/en/news/news1365037557756970080.html Tue, 10 May 2011 15:00:00 GMT ef859bd5-c076-45d1-bbf1-2aa4f3d3949c 2011-05-10T15:00:00Z Notice Regarding the Impact of the Great East Japan Earthquake(Second Report) https://www.seikagaku.co.jp/en/news/news-4668352240350483764.html Sun, 10 Apr 2011 15:00:00 GMT 2f9f1e29-7c34-4db2-94a2-c2bd78cb2a4e 2011-04-10T15:00:00Z Seikagaku Announces Withdrawal of PMA for Additional Indication of SUPARTZ® in the U.S. https://www.seikagaku.co.jp/en/news/news7632704758101139732.html Tue, 29 Mar 2011 15:00:00 GMT 8e5c6249-a17f-4e81-9fca-5d4e457437af 2011-03-29T15:00:00Z Seikagaku Announces the Discontinuation of Research Reagent Business at Its Subsidiary https://www.seikagaku.co.jp/en/news/news5108587154690188323.html Mon, 28 Mar 2011 15:00:00 GMT cee9dd9a-1ef6-45bf-9966-0c1ab6f38526 2011-03-28T15:00:00Z Seikagaku announces U.S. FDA approval of Gel-One, a single injection Hyaluronic Acid injectable treatment for osteoarthritis pain of the knee. https://www.seikagaku.co.jp/en/news/news6066006021700493893.html Wed, 23 Mar 2011 15:00:00 GMT e91f4f3f-e690-485e-9583-d84a59fb5887 2011-03-23T15:00:00Z Notice regarding the impact of the Tohoku Pacific Offshore Earthquake https://www.seikagaku.co.jp/en/news/news7132943256590140054.html Tue, 15 Mar 2011 15:00:00 GMT fb431073-a1a5-4ef9-a8c7-7137d667b968 2011-03-15T15:00:00Z Consolidated Financial Results for the Third Quarter of Fiscal 2010 https://www.seikagaku.co.jp/en/news/news-8044007776013115318.html Mon, 31 Jan 2011 15:00:00 GMT 2b7dd3c2-76b9-40e6-ace0-0c575a2a4a7a 2011-01-31T15:00:00Z Seikagaku announces on top-line results from phase II/III clinical trial in Japan of SI-6603, indicated for treatment on lumbar disc herniation https://www.seikagaku.co.jp/en/news/news8353224371238138975.html Mon, 13 Dec 2010 15:00:00 GMT 1dad0cd5-8bac-4b0d-8851-cccdbff96f52 2010-12-13T15:00:00Z Consolidated Financial Results for the Second Quarter of Fiscal 2010 https://www.seikagaku.co.jp/en/news/news-1139786281247346441.html Mon, 08 Nov 2010 15:00:00 GMT 3077d25e-cba7-45ef-9d6c-d4895d396a5c 2010-11-08T15:00:00Z Consolidated Financial Results for the First Quarter of Fiscal Year 2010 https://www.seikagaku.co.jp/en/news/news5862927576919443177.html Thu, 29 Jul 2010 15:00:00 GMT f7f64aff-355a-4d4c-8ce9-2a9420364329 2010-07-29T15:00:00Z Seikagaku Corporation submits Amendment to Premarket Approval Application for Gel-200 to U.S. Food and Drug Administration https://www.seikagaku.co.jp/en/news/news-8243911603934770397.html Thu, 24 Jun 2010 15:00:00 GMT 690a1e3e-dacb-46f8-a3aa-d8b801ab06a0 2010-06-24T15:00:00Z Consolidated Financial Results for Fiscal 2009 (Year Ended March 31, 2010) https://www.seikagaku.co.jp/en/news/news-810911525834179858.html Mon, 10 May 2010 15:00:00 GMT 3e741d45-ce81-452a-b702-b6a839fb9875 2010-05-10T15:00:00Z Consolidated Financial Results for the Third Quarter of Fiscal 2009 https://www.seikagaku.co.jp/en/news/news130971769768710923.html Mon, 01 Feb 2010 15:00:00 GMT 76ad9ec9-62cf-4a22-9280-ca04e07292bd 2010-02-01T15:00:00Z Receipt of Result for the U.S. PMA of Gel-200 https://www.seikagaku.co.jp/en/news/news-6472283549153189735.html Thu, 07 Jan 2010 15:00:00 GMT e76386fb-8c00-451f-9b4d-84cfb4e49777 2010-01-07T15:00:00Z Consolidated Financial Results for the Second Quarter of Fiscal 2009 https://www.seikagaku.co.jp/en/news/news-5096853507534340739.html Thu, 05 Nov 2009 15:00:00 GMT 99d3f4ee-b2d9-445f-b48b-71b314d3b71c 2009-11-05T15:00:00Z The application of SUPARTZ® was submitted to FDA for additional indication of treatment of pain associated with shoulder osteoarthritis https://www.seikagaku.co.jp/en/news/news1718559615793905445.html Sun, 27 Sep 2009 15:00:00 GMT 1e11ba6a-6fa3-4828-b0c6-99113376d712 2009-09-27T15:00:00Z Consolidated Financial Results for the First Three Months of Fiscal 2009 https://www.seikagaku.co.jp/en/news/news1448232210935423664.html Thu, 30 Jul 2009 15:00:00 GMT 8c858582-4ecb-462c-8cb7-31a2633de563 2009-07-30T15:00:00Z Conclusion of an Exclusive Distributorship Agreement for Gel-200 with Zimmer, Inc. of the U.S. https://www.seikagaku.co.jp/en/news/news-5047392556995352301.html Thu, 28 May 2009 15:00:00 GMT 81cf888f-9d57-44e4-8c72-fcc4227b738e 2009-05-28T15:00:00Z Consolidated Financial Results for Fiscal 2008 (Year Ended March 31, 2009) https://www.seikagaku.co.jp/en/news/news5745014087353899816.html Mon, 11 May 2009 15:00:00 GMT c4640320-4594-468a-8f5c-6d3a604d9093 2009-05-11T15:00:00Z Announcement of the Mid-term Management Plan https://www.seikagaku.co.jp/en/news/news-5571004117090431947.html Mon, 09 Mar 2009 15:00:00 GMT b95eb44d-cbf0-4c86-a636-537927b0054f 2009-03-09T15:00:00Z Consolidated Financial Results for the First Nine Months of Fiscal 2008 https://www.seikagaku.co.jp/en/news/news9196308385353114565.html Mon, 02 Feb 2009 15:00:00 GMT 09ac028f-f19b-4ac1-b284-6abc9c25c77c 2009-02-02T15:00:00Z